Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2000
03/02/2000CA2339537A1 Regulation of substrate activity
03/02/2000CA2339372A1 New compounds
03/02/2000CA2339286A1 New compounds
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/02/2000CA2338688A1 Oral mucoadhesive compositions containing gastrointestinal actives
03/02/2000CA2338639A1 Toothpaste comprising fine and coarse calcium carbonate
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0982297A2 Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists
03/01/2000EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
03/01/2000EP0981620A1 Hgf polypeptides and their use in therapy
03/01/2000EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors
03/01/2000EP0981374A2 Sustained-release delayed gels
03/01/2000EP0981362A1 Methods of enhancing functioning of the upper gastrointestinal tract
03/01/2000EP0981360A1 Method for preventing gastritis using amylin or amylin agonists
03/01/2000EP0981335A1 An enteric coated oral dosage form comprising sodium amoxycillin
03/01/2000EP0857063A4 Compositions and methods for buccal delivery of pharmaceutical agents
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments
03/01/2000CN1245799A Preparation method of pyrrolidyl hydroxamic acid compound
03/01/2000CN1245717A Chinese patent medicine for curing diarrhea
03/01/2000CN1245709A Chinese medicine for curing lithiasis
03/01/2000CN1245700A Chinese medicine for curing appendicitis
03/01/2000CN1245691A Chinese plaster for curing liver diseases and its preparation method
03/01/2000CN1245689A Preparation method of bee afterbirth extract (bee frison extract) and its application
03/01/2000CN1245687A Double regulation nutrient health-care product and its preparation method
03/01/2000CN1245686A Compound Niuduning oral liquor and its preparation method
03/01/2000CA2246791A1 Treatment of endothelium with somatostatin analogues
02/2000
02/29/2000US6031114 Process for pyrrolidinyl hydroxamic acid compounds
02/29/2000US6031111 Indolin-2-one derivatives
02/29/2000US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse;
02/29/2000US6030953 For preventing and treating anal leakage of oil in a patient
02/29/2000US6030946 Reversible cysteine protease inhibitors
02/29/2000US6030798 Method of identifying a lipase for treatment of digestive disorders
02/29/2000CA2280049A1 Diarylsulfonylurea binding proteins
02/24/2000WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009558A1 Hepatitis c inhibitor peptides
02/24/2000WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them
02/24/2000WO2000009543A2 Hepatitis c inhibitor tri-peptides
02/24/2000WO2000009512A2 Bipyridine manganese complexes
02/24/2000WO2000009507A1 Phenyl yanthine derivatives
02/24/2000WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
02/24/2000WO2000009503A1 Integrin receptor antagonists
02/24/2000WO2000009498A1 Prodrugs of proton pump inhibitors
02/24/2000WO2000009497A1 Improved omeprazole process and compositions thereof
02/24/2000WO2000009496A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
02/24/2000WO2000009492A1 Tace inhibitors
02/24/2000WO2000009491A1 Calcilytic compounds
02/24/2000WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/24/2000WO2000009156A1 Non-virulent porphyromonas gingivalis mutant
02/24/2000WO2000009146A1 Treatment of disease states
02/24/2000WO2000009132A1 Calcilytic compounds
02/24/2000WO2000009123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan
02/24/2000WO2000009092A1 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
02/24/2000WO2000009090A1 Orally disintegrable tablet forming a viscous slurry
02/24/2000WO2000009080A1 Incorporation of exogenous lactic bacteria into the oral microflora
02/24/2000WO2000008948A2 Carbohydrate mixture
02/24/2000WO2000008946A1 Protein component for dietetic food
02/24/2000WO2000002579A3 Component b as angiogenic agent in combination with human growth factors
02/24/2000WO2000001372A3 Chewable oral unit dosage
02/24/2000WO1999057133A3 Inhibitors of nf-kb activation
02/24/2000WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same
02/24/2000DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections
02/24/2000DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections
02/24/2000DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis
02/24/2000DE19836339A1 Carbohydrate mixture comprising oligosaccharide and polysaccharide components with prebiotic properties useful as nutritional supplement or as pharmaceutical
02/24/2000DE19836338A1 Dephosphorylated protein component useful in dietetic foods for subjects with gastrointenstinal motility disorders
02/24/2000CA2740912A1 Carbohydrate mixtures
02/24/2000CA2341216A1 Bipyridine manganese complexes
02/24/2000CA2340350A1 Phenyl yanthine derivatives
02/24/2000CA2340341A1 Calcilytic compounds
02/24/2000CA2340257A1 Treatment of disease states
02/24/2000CA2340182A1 Tace inhibitors
02/24/2000CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones
02/24/2000CA2340068A1 Calcilytic compounds
02/24/2000CA2339757A1 Protein component for dietetic food
02/24/2000CA2339418A1 Human chordin-related proteins and polynucleotides encoding them
02/24/2000CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000CA2338967A1 Improved omeprazole process and compositions thereof
02/24/2000CA2338878A1 Integrin receptor antagonists
02/24/2000CA2277242A1 Process for pyrrolidinyl hydroxamic acid compounds
02/23/2000EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/23/2000EP0980374A1 Phosphodiesterase 4-inhibiting diazepinoindolones
02/23/2000EP0980370A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
02/23/2000EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders
02/23/2000EP0980368A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
02/23/2000EP0980351A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
02/23/2000EP0980246A1 Therapy for constipation
02/23/2000EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES
02/23/2000EP0861252B1 Naphthamide derivatives of 3 beta-amino azabicyclo octane or nonane as neuroleptic agents
02/23/2000CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity
02/23/2000CN1245432A Absorbable composition containing propionic bacteria capable of releasing nitric oxide in human or animal alimentary canal
02/23/2000CN1245430A Prophylactic and therapeutic agent for inflammatory intestinal diseases
02/23/2000CN1245428A Use of 7-(2-oxa-5,8-diazabicyclo [4,3,0] non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for treatment of helicobacter pylori infections and associated gastroduodenal
02/23/2000CN1245399A Method of biological control
02/23/2000CN1245398A Method of biological control
02/23/2000CN1245073A Placenta-cordyceps capsule for treating virus hepatitis
02/23/2000CN1245067A Medicine for conditioning intestine and treating diarrhea
02/23/2000CN1245065A Medicine for treating hepatism
02/23/2000CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B
1 ... 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 ... 1258